| 生物活性 |
Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia.
|
|---|---|
| 分子量 |
145.34 kDa
|
| CAS号 |
2225109-03-3
|
| 中文名称 |
TAFOLECIMAB (托莱西单抗 )
|
| 运输条件 |
Shipping with dry ice.
|
| 储存方式 |
Store at -20˚C
|
纯度： 95%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet